FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 352:933-934 March 3, 2005 Number 9 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

It is often tempting to abandon old ways for glamorous new ones. Such is certainly the case for antibiotic development. However, a recent study by Andries and colleagues¹ shows that established methods, enhanced by modern techniques, can be used to generate exciting results.

Traditionally, we have identified antibiotics by looking for compounds that block microbial growth. Since many pathogens can easily be cultured, it is a straightforward matter to screen large numbers of compounds in order to identify any that inhibit the growth of these pathogens. This strategy has several advantages. First, there is no need to guess which microbial . . . [Full Text of this Article]

Source Information

From the School of Public Health, Harvard University, Boston.

This article has been cited by other articles:

• Nettleman, M. D. (2005). Multidrug-Resistant Tuberculosis: News From the Front. JAMA 293: 2788-2790 [Full Text]  
• Davies, P. (2005). An action plan for tuberculosis in England. JRSM 98: 247-248 [Full Text]